Americans want doc payments disclosed

Apparently, it's not just a few activist Congressional reps who want doctors to fess up to payments from pharmaceutical companies. A new poll found that Americans want to know whether their physicians are getting gifts or payments from drugmakers. The Prescription Project's survey showed that more than half of respondents thought they should know their doctors' relationships with pharma, but only a third said they'd be willing to ask directly.

Hence the move toward mandating disclosure, one version of which is making its way through the Senate as we speak. This survey showed that the public supports mandatory disclosure--by a margin of 2 to 1. That's not surprising, considering that half of the respondents believe doctors' prescribing habits are influenced by pharma gifts and payments.

- read the item at the Boston Globe
- check out the Pharmalot post

Suggested Articles

Alnylam is ready to follow on its Onpattro launch with an FDA nod for Givlaari. But the drug's safety profile is giving analysts reason to pause.

FDA nominee Stephen Hahn faced questions from Senators on Wednesday on topics including drug pricing, biosimilars, opioids and more.

BMS’ Opdivo-Yervoy combo been game-changing in late-stage melanoma. But when it comes to expanding the pair’s reach, the company has hit a roadblock.